UBS Group
IQMDU

UBS Group’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

UBS Group’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$1.01K – 10365
2023
Q1 		$1.01K Sell
100
-1,381
-93% -$14.2K ﹤0.01% 8854
2022
Q4 		$15.2K Buy
1,481
+1,433
+2,985% +$14.6K ﹤0.01% 8009
2022
Q3 		$0 Buy
+48
New +$484 ﹤0.01% 11426

Other funds holding IQMDU

RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return

UBS Group's IQMDU Position: Q2 2023 in Review

UBS Group sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q2 2023, closing a stake of 100 shares — an estimated $1.01K sold.

UBS Group first reported a position in IQMDU in Q3 2022 and held it in 3 quarters. The position peaked at $15.2K in Q4 2022. 1 fund tracked by Wall St. Rank holds IQMDU as of Q2 2023.

  • UBS Group reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 100 Intelligent Medicine Acquisition Corp. Unit shares in Q2 2023, an estimated $1.01K.
  • UBS Group first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q3 2022 and held it in 3 quarters.
  • UBS Group's Intelligent Medicine Acquisition Corp. Unit position peaked at $15.2K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.